It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

The price isn’t going to come down anytime soon, but creator Novo Nordisk might have a workaround for people afraid of needles. The drug manufacturer has developed a pill that could bring about ...

Novo Nordisk's weight-loss drugs ... What's more, many patients are afraid of needles, and there's pain associated with receiving injections. Conversely, very few people experience pain when ...

On Sept. 16 Novo Nordisk (NYSE: NVO) and Korro Bio (NASDAQ: KRRO) announced that they'd be starting a new drug-development collaboration worth hundreds of millions of dollars, in an area that most ...

Ozempic (semaglutide) is a once-weekly injectable medication that helps treat type 2 diabetes and reduces the risk of ...

Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition ...

Semaglutide is approved as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes and as Wegovy for obesity. We remind the investors that Novo Nordisk had previously presented ...

Novo Nordisk has been slowly increasing production capacity of its highly coveted weight loss drugs. As a result, thousands of people have began treatment per week. Wegovy has been FDA-approved ...

Safety Needles Market size is estimated to soar to a notable USD 11,972.7 million by 2033 projected CAGR of 7.4%.